Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

phosphatase/atrofija

Povezava se shrani v odložišče
7 rezultatov

Gene encoding vitamin b.sub.6 phosphate phosphatase and use thereof

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
This application is the Nation Stage of International Application NO. PCT/EP2003/01575, filed Sep. 23, 2003. The present invention relates to a novel vitamin B.sub.6 phosphate phosphatase (VB6P phosphatase) gene, recombinant microorganisms transformed with a vector having the gene, and a polypeptide

Alkaline and acid phosphatase inhibitors in treatment of neurological disorders

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION The present invention relates to the use of alkaline and acid phosphatase inhibitors in the treatment of neurological disorders. More particularly, the present invention relates to the use of various specific phosphatase inhibitors in the treatment of .beta.-amyloid toxicity
The present invention relates to the use of carprofen in mammals as a means of treating and preventing cartilage and subchondral bone injury and loss in the inflamed joints of such mammals. Such damage to the cartilage and subchondral bone is a natural sequelae of the process of osteoarthritis and

Stimulating nerve growth with immunophilins

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND OF THE INVENTION The immunosuppressant drugs cyclosporin A and FK506 are thought to exert their therapeutic effects by binding to receptor proteins, designated cyclophilins and FK506 binding proteins (FKBP) respectively. When complexed to the immunosuppressant drugs, these binding

Treatment of tauopathies with mGluR5 antagonists

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the treatment of tauopathies and, more specifically, the use of mGluR5 antagonists for the treatment of tau pathologies. 2. Description of the Related Art Indigenous residents and immigrants of the Pacific Island
BACKGROUND OF THE INVENTION The immunosuppressant drugs cyclosporin A and FK506 are thought to exert their therapeutic effects by binding to receptor proteins, designated cyclophilins and FK506 binding proteins (FKBP) respectively. When complexed to the immunosuppressant drugs, these binding

Pharmaceutical composition for preventing or treating neurodegenerative diseases

Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority of Korean Patent Applications Nos. KR 10-2015-0100430, filed Jul. 15, 2015 and KR 10-2015-0100481, filed Jul. 15, 2015, the contents of each of which are hereby incorporated by reference into the application. REFERENCE TO A
Pridružite se naši
facebook strani

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

  • Deluje v 55 jezikih
  • Zeliščna zdravila, podprta z znanostjo
  • Prepoznavanje zelišč po sliki
  • Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
  • Preberite znanstvene publikacije, povezane z vašim iskanjem
  • Iščite zdravilna zelišča po njihovih učinkih
  • Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah

Google Play badgeApp Store badge